monoclonal antibody therapy targeting GD2

anti-GD2 monoclonal antibody

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for monoclonal antibody therapy targeting GD2, covering 2013-01-16 to 2013-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma [Phase 1]